Period
recent search
Showing: 1 – 05 of 171 Regulated Information
31 October 2023
31 October 2023
26 October 2023
26 October 2023
Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance
Paris (France), 26 October 2023
24 October 2023
24 October 2023
IPSEN – Buy-back program – Art 5 of MAR – Week 42 – 2023
Aggregated presentation by day and by market
16 August 2023
16 August 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 32 – 2023
Aggregated presentation by day and by market
27 July 2023
27 July 2023
Ipsen delivers solid H1 2023 results and upgrades its full-year guidance
Paris, France: 27 July 2023Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, presents today its financial results for the first half of 2023.